nodes	percent_of_prediction	percent_of_DWPC	metapath
Penicillamine—Bone marrow depression—Doxorubicin—ovarian cancer	0.00296	0.00296	CcSEcCtD
Penicillamine—Agranulocytosis—Vinorelbine—ovarian cancer	0.00293	0.00293	CcSEcCtD
Penicillamine—Alopecia—Topotecan—ovarian cancer	0.00291	0.00291	CcSEcCtD
Penicillamine—Dermatitis exfoliative—Paclitaxel—ovarian cancer	0.00291	0.00291	CcSEcCtD
Penicillamine—Leukopenia—Chlorambucil—ovarian cancer	0.00289	0.00289	CcSEcCtD
Penicillamine—Alopecia—Melphalan—ovarian cancer	0.00285	0.00285	CcSEcCtD
Penicillamine—Rash erythematous—Epirubicin—ovarian cancer	0.00282	0.00282	CcSEcCtD
Penicillamine—Hypoglycaemia—Paclitaxel—ovarian cancer	0.00281	0.00281	CcSEcCtD
Penicillamine—Thrombophlebitis—Docetaxel—ovarian cancer	0.00269	0.00269	CcSEcCtD
Penicillamine—Blood alkaline phosphatase increased—Docetaxel—ovarian cancer	0.00267	0.00267	CcSEcCtD
Penicillamine—Ageusia—Epirubicin—ovarian cancer	0.00267	0.00267	CcSEcCtD
Penicillamine—Anaemia—Topotecan—ovarian cancer	0.00265	0.00265	CcSEcCtD
Penicillamine—Rash erythematous—Doxorubicin—ovarian cancer	0.00261	0.00261	CcSEcCtD
Penicillamine—Anaemia—Melphalan—ovarian cancer	0.0026	0.0026	CcSEcCtD
Penicillamine—Hepatic failure—Docetaxel—ovarian cancer	0.00259	0.00259	CcSEcCtD
Penicillamine—Thrombocytopenia—Chlorambucil—ovarian cancer	0.00258	0.00258	CcSEcCtD
Penicillamine—Leukopenia—Topotecan—ovarian cancer	0.00257	0.00257	CcSEcCtD
Penicillamine—Angiopathy—Vinorelbine—ovarian cancer	0.00256	0.00256	CcSEcCtD
Penicillamine—Leukopenia—Melphalan—ovarian cancer	0.00252	0.00252	CcSEcCtD
Penicillamine—Anorexia—Chlorambucil—ovarian cancer	0.00251	0.00251	CcSEcCtD
Penicillamine—Abdominal pain upper—Paclitaxel—ovarian cancer	0.0025	0.0025	CcSEcCtD
Penicillamine—Alopecia—Vinorelbine—ovarian cancer	0.00249	0.00249	CcSEcCtD
Penicillamine—Extravasation—Epirubicin—ovarian cancer	0.00248	0.00248	CcSEcCtD
Penicillamine—Toxic epidermal necrolysis—Paclitaxel—ovarian cancer	0.00247	0.00247	CcSEcCtD
Penicillamine—Ageusia—Doxorubicin—ovarian cancer	0.00247	0.00247	CcSEcCtD
Penicillamine—Arthralgia—Topotecan—ovarian cancer	0.00244	0.00244	CcSEcCtD
Penicillamine—Unspecified disorder of skin and subcutaneous tissue—Topotecan—ovarian cancer	0.00243	0.00243	CcSEcCtD
Penicillamine—Muscular weakness—Paclitaxel—ovarian cancer	0.00242	0.00242	CcSEcCtD
Penicillamine—Unspecified disorder of skin and subcutaneous tissue—Melphalan—ovarian cancer	0.00238	0.00238	CcSEcCtD
Penicillamine—Glossitis—Epirubicin—ovarian cancer	0.00234	0.00234	CcSEcCtD
Penicillamine—Pancreatitis—Paclitaxel—ovarian cancer	0.00232	0.00232	CcSEcCtD
Penicillamine—Thrombocytopenia—Topotecan—ovarian cancer	0.00229	0.00229	CcSEcCtD
Penicillamine—Extravasation—Doxorubicin—ovarian cancer	0.00229	0.00229	CcSEcCtD
Penicillamine—Decreased appetite—Chlorambucil—ovarian cancer	0.00229	0.00229	CcSEcCtD
Penicillamine—Skin disorder—Topotecan—ovarian cancer	0.00228	0.00228	CcSEcCtD
Penicillamine—Anaemia—Vinorelbine—ovarian cancer	0.00227	0.00227	CcSEcCtD
Penicillamine—Pancytopenia—Paclitaxel—ovarian cancer	0.00225	0.00225	CcSEcCtD
Penicillamine—Thrombocytopenia—Melphalan—ovarian cancer	0.00225	0.00225	CcSEcCtD
Penicillamine—Anorexia—Topotecan—ovarian cancer	0.00223	0.00223	CcSEcCtD
Penicillamine—Skin disorder—Melphalan—ovarian cancer	0.00223	0.00223	CcSEcCtD
Penicillamine—Leukopenia—Vinorelbine—ovarian cancer	0.0022	0.0022	CcSEcCtD
Penicillamine—Anorexia—Melphalan—ovarian cancer	0.00219	0.00219	CcSEcCtD
Penicillamine—Glossitis—Doxorubicin—ovarian cancer	0.00217	0.00217	CcSEcCtD
Penicillamine—Musculoskeletal discomfort—Topotecan—ovarian cancer	0.00213	0.00213	CcSEcCtD
Penicillamine—Abdominal pain upper—Docetaxel—ovarian cancer	0.00212	0.00212	CcSEcCtD
Penicillamine—Toxic epidermal necrolysis—Docetaxel—ovarian cancer	0.00209	0.00209	CcSEcCtD
Penicillamine—Urticaria—Chlorambucil—ovarian cancer	0.00209	0.00209	CcSEcCtD
Penicillamine—Arthralgia—Vinorelbine—ovarian cancer	0.00209	0.00209	CcSEcCtD
Penicillamine—Musculoskeletal discomfort—Melphalan—ovarian cancer	0.00209	0.00209	CcSEcCtD
Penicillamine—Body temperature increased—Chlorambucil—ovarian cancer	0.00208	0.00208	CcSEcCtD
Penicillamine—Renal failure—Paclitaxel—ovarian cancer	0.00208	0.00208	CcSEcCtD
Penicillamine—Unspecified disorder of skin and subcutaneous tissue—Vinorelbine—ovarian cancer	0.00208	0.00208	CcSEcCtD
Penicillamine—Neuropathy peripheral—Paclitaxel—ovarian cancer	0.00207	0.00207	CcSEcCtD
Penicillamine—Stomatitis—Paclitaxel—ovarian cancer	0.00206	0.00206	CcSEcCtD
Penicillamine—Decreased appetite—Topotecan—ovarian cancer	0.00204	0.00204	CcSEcCtD
Penicillamine—Aplastic anaemia—Epirubicin—ovarian cancer	0.00203	0.00203	CcSEcCtD
Penicillamine—Neuropathy—Epirubicin—ovarian cancer	0.00203	0.00203	CcSEcCtD
Penicillamine—Haematuria—Paclitaxel—ovarian cancer	0.00201	0.00201	CcSEcCtD
Penicillamine—Hepatobiliary disease—Paclitaxel—ovarian cancer	0.002	0.002	CcSEcCtD
Penicillamine—Decreased appetite—Melphalan—ovarian cancer	0.00199	0.00199	CcSEcCtD
Penicillamine—Thrombocytopenia—Vinorelbine—ovarian cancer	0.00196	0.00196	CcSEcCtD
Penicillamine—Mouth ulceration—Epirubicin—ovarian cancer	0.00195	0.00195	CcSEcCtD
Penicillamine—Skin disorder—Vinorelbine—ovarian cancer	0.00195	0.00195	CcSEcCtD
Penicillamine—Hypersensitivity—Chlorambucil—ovarian cancer	0.00194	0.00194	CcSEcCtD
Penicillamine—Anorexia—Vinorelbine—ovarian cancer	0.00191	0.00191	CcSEcCtD
Penicillamine—Pancytopenia—Docetaxel—ovarian cancer	0.00191	0.00191	CcSEcCtD
Penicillamine—Haemoglobin—Paclitaxel—ovarian cancer	0.00191	0.00191	CcSEcCtD
Penicillamine—Haemorrhage—Paclitaxel—ovarian cancer	0.0019	0.0019	CcSEcCtD
Penicillamine—Neuropathy—Doxorubicin—ovarian cancer	0.00188	0.00188	CcSEcCtD
Penicillamine—Aplastic anaemia—Doxorubicin—ovarian cancer	0.00188	0.00188	CcSEcCtD
Penicillamine—Urinary tract disorder—Paclitaxel—ovarian cancer	0.00187	0.00187	CcSEcCtD
Penicillamine—Urticaria—Topotecan—ovarian cancer	0.00186	0.00186	CcSEcCtD
Penicillamine—Urethral disorder—Paclitaxel—ovarian cancer	0.00186	0.00186	CcSEcCtD
Penicillamine—Body temperature increased—Topotecan—ovarian cancer	0.00185	0.00185	CcSEcCtD
Penicillamine—Lymphadenopathy—Epirubicin—ovarian cancer	0.00184	0.00184	CcSEcCtD
Penicillamine—Musculoskeletal discomfort—Vinorelbine—ovarian cancer	0.00183	0.00183	CcSEcCtD
Penicillamine—Urticaria—Melphalan—ovarian cancer	0.00182	0.00182	CcSEcCtD
Penicillamine—Thrombophlebitis—Epirubicin—ovarian cancer	0.00181	0.00181	CcSEcCtD
Penicillamine—Mouth ulceration—Doxorubicin—ovarian cancer	0.00181	0.00181	CcSEcCtD
Penicillamine—Blood alkaline phosphatase increased—Epirubicin—ovarian cancer	0.0018	0.0018	CcSEcCtD
Penicillamine—Diarrhoea—Chlorambucil—ovarian cancer	0.0018	0.0018	CcSEcCtD
Penicillamine—Hepatic function abnormal—Epirubicin—ovarian cancer	0.00179	0.00179	CcSEcCtD
Penicillamine—Tinnitus—Paclitaxel—ovarian cancer	0.00177	0.00177	CcSEcCtD
Penicillamine—Renal failure—Docetaxel—ovarian cancer	0.00176	0.00176	CcSEcCtD
Penicillamine—Neuropathy peripheral—Docetaxel—ovarian cancer	0.00176	0.00176	CcSEcCtD
Penicillamine—Stomatitis—Docetaxel—ovarian cancer	0.00175	0.00175	CcSEcCtD
Penicillamine—Hepatic failure—Epirubicin—ovarian cancer	0.00174	0.00174	CcSEcCtD
Penicillamine—Decreased appetite—Vinorelbine—ovarian cancer	0.00174	0.00174	CcSEcCtD
Penicillamine—Hypersensitivity—Topotecan—ovarian cancer	0.00173	0.00173	CcSEcCtD
Penicillamine—Angiopathy—Paclitaxel—ovarian cancer	0.00172	0.00172	CcSEcCtD
Penicillamine—Lymphadenopathy—Doxorubicin—ovarian cancer	0.0017	0.0017	CcSEcCtD
Penicillamine—Hepatobiliary disease—Docetaxel—ovarian cancer	0.00169	0.00169	CcSEcCtD
Penicillamine—Hypersensitivity—Melphalan—ovarian cancer	0.00169	0.00169	CcSEcCtD
Penicillamine—Alopecia—Paclitaxel—ovarian cancer	0.00168	0.00168	CcSEcCtD
Penicillamine—Thrombophlebitis—Doxorubicin—ovarian cancer	0.00168	0.00168	CcSEcCtD
Penicillamine—Vomiting—Chlorambucil—ovarian cancer	0.00167	0.00167	CcSEcCtD
Penicillamine—Agranulocytosis—Docetaxel—ovarian cancer	0.00167	0.00167	CcSEcCtD
Penicillamine—Blood alkaline phosphatase increased—Doxorubicin—ovarian cancer	0.00167	0.00167	CcSEcCtD
Penicillamine—Mental disorder—Paclitaxel—ovarian cancer	0.00166	0.00166	CcSEcCtD
Penicillamine—Dermatitis exfoliative—Epirubicin—ovarian cancer	0.00166	0.00166	CcSEcCtD
Penicillamine—Hepatic function abnormal—Doxorubicin—ovarian cancer	0.00166	0.00166	CcSEcCtD
Penicillamine—Dysgeusia—Paclitaxel—ovarian cancer	0.00162	0.00162	CcSEcCtD
Penicillamine—Haemoglobin—Docetaxel—ovarian cancer	0.00162	0.00162	CcSEcCtD
Penicillamine—Hepatic failure—Doxorubicin—ovarian cancer	0.00161	0.00161	CcSEcCtD
Penicillamine—Haemorrhage—Docetaxel—ovarian cancer	0.00161	0.00161	CcSEcCtD
Penicillamine—Hypoglycaemia—Epirubicin—ovarian cancer	0.00161	0.00161	CcSEcCtD
Penicillamine—Diarrhoea—Topotecan—ovarian cancer	0.0016	0.0016	CcSEcCtD
Penicillamine—Urticaria—Vinorelbine—ovarian cancer	0.00159	0.00159	CcSEcCtD
Penicillamine—Urinary tract disorder—Docetaxel—ovarian cancer	0.00159	0.00159	CcSEcCtD
Penicillamine—Body temperature increased—Vinorelbine—ovarian cancer	0.00158	0.00158	CcSEcCtD
Penicillamine—Urethral disorder—Docetaxel—ovarian cancer	0.00158	0.00158	CcSEcCtD
Penicillamine—Diarrhoea—Melphalan—ovarian cancer	0.00157	0.00157	CcSEcCtD
Penicillamine—Nausea—Chlorambucil—ovarian cancer	0.00156	0.00156	CcSEcCtD
Penicillamine—Dermatitis exfoliative—Doxorubicin—ovarian cancer	0.00154	0.00154	CcSEcCtD
Penicillamine—Anaemia—Paclitaxel—ovarian cancer	0.00153	0.00153	CcSEcCtD
Penicillamine—Agitation—Paclitaxel—ovarian cancer	0.00152	0.00152	CcSEcCtD
Penicillamine—Vomiting—Topotecan—ovarian cancer	0.00149	0.00149	CcSEcCtD
Penicillamine—Hypoglycaemia—Doxorubicin—ovarian cancer	0.00149	0.00149	CcSEcCtD
Penicillamine—Leukopenia—Paclitaxel—ovarian cancer	0.00148	0.00148	CcSEcCtD
Penicillamine—Rash—Topotecan—ovarian cancer	0.00148	0.00148	CcSEcCtD
Penicillamine—Hypersensitivity—Vinorelbine—ovarian cancer	0.00148	0.00148	CcSEcCtD
Penicillamine—Dermatitis—Topotecan—ovarian cancer	0.00148	0.00148	CcSEcCtD
Penicillamine—Angiopathy—Docetaxel—ovarian cancer	0.00146	0.00146	CcSEcCtD
Penicillamine—Vomiting—Melphalan—ovarian cancer	0.00146	0.00146	CcSEcCtD
Penicillamine—Rash—Melphalan—ovarian cancer	0.00145	0.00145	CcSEcCtD
Penicillamine—Dermatitis—Melphalan—ovarian cancer	0.00144	0.00144	CcSEcCtD
Penicillamine—Abdominal pain upper—Epirubicin—ovarian cancer	0.00143	0.00143	CcSEcCtD
Penicillamine—Alopecia—Docetaxel—ovarian cancer	0.00142	0.00142	CcSEcCtD
Penicillamine—Toxic epidermal necrolysis—Epirubicin—ovarian cancer	0.00141	0.00141	CcSEcCtD
Penicillamine—Mental disorder—Docetaxel—ovarian cancer	0.00141	0.00141	CcSEcCtD
Penicillamine—Arthralgia—Paclitaxel—ovarian cancer	0.00141	0.00141	CcSEcCtD
Penicillamine—Anxiety—Paclitaxel—ovarian cancer	0.0014	0.0014	CcSEcCtD
Penicillamine—Unspecified disorder of skin and subcutaneous tissue—Paclitaxel—ovarian cancer	0.0014	0.0014	CcSEcCtD
Penicillamine—Nausea—Topotecan—ovarian cancer	0.00139	0.00139	CcSEcCtD
Penicillamine—Muscular weakness—Epirubicin—ovarian cancer	0.00138	0.00138	CcSEcCtD
Penicillamine—Diarrhoea—Vinorelbine—ovarian cancer	0.00137	0.00137	CcSEcCtD
Penicillamine—Dysgeusia—Docetaxel—ovarian cancer	0.00137	0.00137	CcSEcCtD
Penicillamine—Nausea—Melphalan—ovarian cancer	0.00136	0.00136	CcSEcCtD
Penicillamine—Asthma—Epirubicin—ovarian cancer	0.00136	0.00136	CcSEcCtD
Penicillamine—Eosinophilia—Epirubicin—ovarian cancer	0.00134	0.00134	CcSEcCtD
Penicillamine—Pancreatitis—Epirubicin—ovarian cancer	0.00133	0.00133	CcSEcCtD
Penicillamine—Abdominal pain upper—Doxorubicin—ovarian cancer	0.00132	0.00132	CcSEcCtD
Penicillamine—Thrombocytopenia—Paclitaxel—ovarian cancer	0.00132	0.00132	CcSEcCtD
Penicillamine—Skin disorder—Paclitaxel—ovarian cancer	0.00131	0.00131	CcSEcCtD
Penicillamine—Toxic epidermal necrolysis—Doxorubicin—ovarian cancer	0.00131	0.00131	CcSEcCtD
Penicillamine—Anaemia—Docetaxel—ovarian cancer	0.00129	0.00129	CcSEcCtD
Penicillamine—Pancytopenia—Epirubicin—ovarian cancer	0.00129	0.00129	CcSEcCtD
Penicillamine—Anorexia—Paclitaxel—ovarian cancer	0.00128	0.00128	CcSEcCtD
Penicillamine—Muscular weakness—Doxorubicin—ovarian cancer	0.00128	0.00128	CcSEcCtD
Penicillamine—Vomiting—Vinorelbine—ovarian cancer	0.00127	0.00127	CcSEcCtD
Penicillamine—Rash—Vinorelbine—ovarian cancer	0.00126	0.00126	CcSEcCtD
Penicillamine—Dermatitis—Vinorelbine—ovarian cancer	0.00126	0.00126	CcSEcCtD
Penicillamine—Asthma—Doxorubicin—ovarian cancer	0.00125	0.00125	CcSEcCtD
Penicillamine—Leukopenia—Docetaxel—ovarian cancer	0.00125	0.00125	CcSEcCtD
Penicillamine—Eosinophilia—Doxorubicin—ovarian cancer	0.00124	0.00124	CcSEcCtD
Penicillamine—Pancreatitis—Doxorubicin—ovarian cancer	0.00123	0.00123	CcSEcCtD
Penicillamine—Musculoskeletal discomfort—Paclitaxel—ovarian cancer	0.00123	0.00123	CcSEcCtD
Penicillamine—Arthralgia—Docetaxel—ovarian cancer	0.00119	0.00119	CcSEcCtD
Penicillamine—Pancytopenia—Doxorubicin—ovarian cancer	0.00119	0.00119	CcSEcCtD
Penicillamine—Nausea—Vinorelbine—ovarian cancer	0.00119	0.00119	CcSEcCtD
Penicillamine—Renal failure—Epirubicin—ovarian cancer	0.00119	0.00119	CcSEcCtD
Penicillamine—Neuropathy peripheral—Epirubicin—ovarian cancer	0.00118	0.00118	CcSEcCtD
Penicillamine—Unspecified disorder of skin and subcutaneous tissue—Docetaxel—ovarian cancer	0.00118	0.00118	CcSEcCtD
Penicillamine—Stomatitis—Epirubicin—ovarian cancer	0.00118	0.00118	CcSEcCtD
Penicillamine—Decreased appetite—Paclitaxel—ovarian cancer	0.00117	0.00117	CcSEcCtD
Penicillamine—Haematuria—Epirubicin—ovarian cancer	0.00115	0.00115	CcSEcCtD
Penicillamine—Hepatobiliary disease—Epirubicin—ovarian cancer	0.00114	0.00114	CcSEcCtD
Penicillamine—Agranulocytosis—Epirubicin—ovarian cancer	0.00113	0.00113	CcSEcCtD
Penicillamine—Thrombocytopenia—Docetaxel—ovarian cancer	0.00112	0.00112	CcSEcCtD
Penicillamine—Skin disorder—Docetaxel—ovarian cancer	0.00111	0.00111	CcSEcCtD
Penicillamine—Renal failure—Doxorubicin—ovarian cancer	0.0011	0.0011	CcSEcCtD
Penicillamine—Neuropathy peripheral—Doxorubicin—ovarian cancer	0.0011	0.0011	CcSEcCtD
Penicillamine—Haemoglobin—Epirubicin—ovarian cancer	0.00109	0.00109	CcSEcCtD
Penicillamine—Stomatitis—Doxorubicin—ovarian cancer	0.00109	0.00109	CcSEcCtD
Penicillamine—Anorexia—Docetaxel—ovarian cancer	0.00109	0.00109	CcSEcCtD
Penicillamine—Haemorrhage—Epirubicin—ovarian cancer	0.00108	0.00108	CcSEcCtD
Penicillamine—Urinary tract disorder—Epirubicin—ovarian cancer	0.00107	0.00107	CcSEcCtD
Penicillamine—Urticaria—Paclitaxel—ovarian cancer	0.00107	0.00107	CcSEcCtD
Penicillamine—Haematuria—Doxorubicin—ovarian cancer	0.00107	0.00107	CcSEcCtD
Penicillamine—Body temperature increased—Paclitaxel—ovarian cancer	0.00107	0.00107	CcSEcCtD
Penicillamine—Urethral disorder—Epirubicin—ovarian cancer	0.00106	0.00106	CcSEcCtD
Penicillamine—Hepatobiliary disease—Doxorubicin—ovarian cancer	0.00106	0.00106	CcSEcCtD
Penicillamine—Agranulocytosis—Doxorubicin—ovarian cancer	0.00104	0.00104	CcSEcCtD
Penicillamine—Musculoskeletal discomfort—Docetaxel—ovarian cancer	0.00104	0.00104	CcSEcCtD
Penicillamine—Tinnitus—Epirubicin—ovarian cancer	0.00101	0.00101	CcSEcCtD
Penicillamine—Haemoglobin—Doxorubicin—ovarian cancer	0.00101	0.00101	CcSEcCtD
Penicillamine—Haemorrhage—Doxorubicin—ovarian cancer	0.001	0.001	CcSEcCtD
Penicillamine—Decreased appetite—Docetaxel—ovarian cancer	0.000993	0.000993	CcSEcCtD
Penicillamine—Hypersensitivity—Paclitaxel—ovarian cancer	0.000993	0.000993	CcSEcCtD
Penicillamine—Urinary tract disorder—Doxorubicin—ovarian cancer	0.000991	0.000991	CcSEcCtD
Penicillamine—Angiopathy—Epirubicin—ovarian cancer	0.000984	0.000984	CcSEcCtD
Penicillamine—Urethral disorder—Doxorubicin—ovarian cancer	0.000984	0.000984	CcSEcCtD
Penicillamine—Alopecia—Epirubicin—ovarian cancer	0.000958	0.000958	CcSEcCtD
Penicillamine—Mental disorder—Epirubicin—ovarian cancer	0.00095	0.00095	CcSEcCtD
Penicillamine—Tinnitus—Doxorubicin—ovarian cancer	0.000936	0.000936	CcSEcCtD
Penicillamine—Dysgeusia—Epirubicin—ovarian cancer	0.000925	0.000925	CcSEcCtD
Penicillamine—Diarrhoea—Paclitaxel—ovarian cancer	0.000922	0.000922	CcSEcCtD
Penicillamine—Angiopathy—Doxorubicin—ovarian cancer	0.000911	0.000911	CcSEcCtD
Penicillamine—Body temperature increased—Docetaxel—ovarian cancer	0.000903	0.000903	CcSEcCtD
Penicillamine—Alopecia—Doxorubicin—ovarian cancer	0.000887	0.000887	CcSEcCtD
Penicillamine—Mental disorder—Doxorubicin—ovarian cancer	0.000879	0.000879	CcSEcCtD
Penicillamine—Anaemia—Epirubicin—ovarian cancer	0.000873	0.000873	CcSEcCtD
Penicillamine—Agitation—Epirubicin—ovarian cancer	0.000868	0.000868	CcSEcCtD
Penicillamine—Vomiting—Paclitaxel—ovarian cancer	0.000857	0.000857	CcSEcCtD
Penicillamine—Dysgeusia—Doxorubicin—ovarian cancer	0.000855	0.000855	CcSEcCtD
Penicillamine—Rash—Paclitaxel—ovarian cancer	0.00085	0.00085	CcSEcCtD
Penicillamine—Dermatitis—Paclitaxel—ovarian cancer	0.000849	0.000849	CcSEcCtD
Penicillamine—Leukopenia—Epirubicin—ovarian cancer	0.000845	0.000845	CcSEcCtD
Penicillamine—Hypersensitivity—Docetaxel—ovarian cancer	0.000842	0.000842	CcSEcCtD
Penicillamine—Anaemia—Doxorubicin—ovarian cancer	0.000807	0.000807	CcSEcCtD
Penicillamine—Arthralgia—Epirubicin—ovarian cancer	0.000804	0.000804	CcSEcCtD
Penicillamine—Agitation—Doxorubicin—ovarian cancer	0.000803	0.000803	CcSEcCtD
Penicillamine—Anxiety—Epirubicin—ovarian cancer	0.000801	0.000801	CcSEcCtD
Penicillamine—Nausea—Paclitaxel—ovarian cancer	0.000801	0.000801	CcSEcCtD
Penicillamine—Unspecified disorder of skin and subcutaneous tissue—Epirubicin—ovarian cancer	0.000798	0.000798	CcSEcCtD
Penicillamine—Leukopenia—Doxorubicin—ovarian cancer	0.000782	0.000782	CcSEcCtD
Penicillamine—Diarrhoea—Docetaxel—ovarian cancer	0.000782	0.000782	CcSEcCtD
Penicillamine—Thrombocytopenia—Epirubicin—ovarian cancer	0.000754	0.000754	CcSEcCtD
Penicillamine—Skin disorder—Epirubicin—ovarian cancer	0.000748	0.000748	CcSEcCtD
Penicillamine—Arthralgia—Doxorubicin—ovarian cancer	0.000744	0.000744	CcSEcCtD
Penicillamine—Anxiety—Doxorubicin—ovarian cancer	0.000741	0.000741	CcSEcCtD
Penicillamine—Unspecified disorder of skin and subcutaneous tissue—Doxorubicin—ovarian cancer	0.000739	0.000739	CcSEcCtD
Penicillamine—Anorexia—Epirubicin—ovarian cancer	0.000735	0.000735	CcSEcCtD
Penicillamine—Vomiting—Docetaxel—ovarian cancer	0.000726	0.000726	CcSEcCtD
Penicillamine—Rash—Docetaxel—ovarian cancer	0.00072	0.00072	CcSEcCtD
Penicillamine—Dermatitis—Docetaxel—ovarian cancer	0.00072	0.00072	CcSEcCtD
Penicillamine—Musculoskeletal discomfort—Epirubicin—ovarian cancer	0.000702	0.000702	CcSEcCtD
Penicillamine—Thrombocytopenia—Doxorubicin—ovarian cancer	0.000698	0.000698	CcSEcCtD
Penicillamine—Skin disorder—Doxorubicin—ovarian cancer	0.000693	0.000693	CcSEcCtD
Penicillamine—Anorexia—Doxorubicin—ovarian cancer	0.00068	0.00068	CcSEcCtD
Penicillamine—Nausea—Docetaxel—ovarian cancer	0.000679	0.000679	CcSEcCtD
Penicillamine—Decreased appetite—Epirubicin—ovarian cancer	0.00067	0.00067	CcSEcCtD
Penicillamine—Musculoskeletal discomfort—Doxorubicin—ovarian cancer	0.00065	0.00065	CcSEcCtD
Penicillamine—Decreased appetite—Doxorubicin—ovarian cancer	0.00062	0.00062	CcSEcCtD
Penicillamine—Urticaria—Epirubicin—ovarian cancer	0.000612	0.000612	CcSEcCtD
Penicillamine—Body temperature increased—Epirubicin—ovarian cancer	0.000609	0.000609	CcSEcCtD
Penicillamine—Hypersensitivity—Epirubicin—ovarian cancer	0.000568	0.000568	CcSEcCtD
Penicillamine—Urticaria—Doxorubicin—ovarian cancer	0.000566	0.000566	CcSEcCtD
Penicillamine—Body temperature increased—Doxorubicin—ovarian cancer	0.000564	0.000564	CcSEcCtD
Penicillamine—Diarrhoea—Epirubicin—ovarian cancer	0.000527	0.000527	CcSEcCtD
Penicillamine—Hypersensitivity—Doxorubicin—ovarian cancer	0.000525	0.000525	CcSEcCtD
Penicillamine—Vomiting—Epirubicin—ovarian cancer	0.00049	0.00049	CcSEcCtD
Penicillamine—Diarrhoea—Doxorubicin—ovarian cancer	0.000488	0.000488	CcSEcCtD
Penicillamine—Rash—Epirubicin—ovarian cancer	0.000486	0.000486	CcSEcCtD
Penicillamine—Dermatitis—Epirubicin—ovarian cancer	0.000485	0.000485	CcSEcCtD
Penicillamine—Nausea—Epirubicin—ovarian cancer	0.000458	0.000458	CcSEcCtD
Penicillamine—Vomiting—Doxorubicin—ovarian cancer	0.000453	0.000453	CcSEcCtD
Penicillamine—Rash—Doxorubicin—ovarian cancer	0.00045	0.00045	CcSEcCtD
Penicillamine—Dermatitis—Doxorubicin—ovarian cancer	0.000449	0.000449	CcSEcCtD
Penicillamine—Nausea—Doxorubicin—ovarian cancer	0.000424	0.000424	CcSEcCtD
